Age and sex in drug development and testing for adults.

Tannenbaum, Cara; Day, Danielle

Tannenbaum, Cara; Day, Danielle.

Affiliation

Tannenbaum C; Institute of Gender and Health, Canadian Institutes of Health Research, Canada; Medicine and Pharmacy, Université de Montreal, Centre de recherche, Institut universitaire de gériatrie de Montréal (CRIUGM), 4565 Chemin Queen-Mary, Montréal, Québec H3W 1W5, Canada. Electronic address: cara.tannenbaum@umontreal.ca.
Day D; Fractyl Laboratories, 17 Hartwell Ave, Lexington, MA 02421, USA.

Pharmacol Res ; 121: 83-93, 2017 Jul.

Article in En | MEDLINE | ID: mdl-28455265

Subject(s)

Drug Discovery/methods; Age Factors; Animals; Clinical Trials as Topic; Female; Humans; Male; Research Design; Sex Factors

Key words

Age; Clinical trials; Dofetilide (PubChem CID: 71329); Drug discovery; Experimental design; Ondansetron (PubChem CID: 4595); Propranolol (PubChem CID: 4946); Quinidine (PubChem CID: 441074); Sex; Tirilazad (PubChem CID: 104903); Zolpidem (PubChem CID: 5732)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Drug Discovery Type of study: Guideline / Risk_factors_studies Limits: Animals / Female / Humans / Male Language: En Journal: Pharmacol Res Journal subject: FARMACOLOGIA Year: 2017 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google